539 studies found for:    "Diabetic Angiopathies"
Show Display Options
Rank Status Study
21 Completed Validation of a Predictive Model to Estimate the Risk of Conversion to Clinically Significant Macular Edema and/or Vision Loss in Mild Nonproliferative Diabetic Retinopathy in Diabetes Type 2
Condition: Diabetic Retinopathy
22 Active, not recruiting Prevention of Secondary Foot Ulcers in Patients With Diabetes Using Systematic Measuring of Skin Temperature.
Condition: Foot Ulcer, Diabetic
Interventions: Device: "Temp Touch" Diabetica Solutions inc.;   Other: Inspection
23 Terminated The Relationship of Hemoglobin A1c and Diabetic Wound Healing
Conditions: Diabetes, Type 1;   Diabetes, Type 2;   Foot Ulcer, Diabetic
Interventions: Drug: Bacitracin;   Drug: AmeriGel®;   Procedure: Hemoglobin A1c;   Dietary Supplement: Vitamin C
24 Active, not recruiting Diabetic Retinopathy in HIV Subjects Treated With EGRIFTA®
Conditions: Diabetic Retinopathy;   HIV
Interventions: Drug: Tesamorelin;   Drug: Placebo-Control
25 Suspended Tracking Optical Coherence Tomography
Conditions: Macular Degeneration;   Glaucoma;   Diabetic Retinopathy;   Choroidal Disease
26 Completed Clinical Trial to Evaluate the Efficacy and Safety of Sodium Bemiparin for Treatment of Diabetic Foot Ulcers
Condition: Foot Ulcer, Diabetic
Interventions: Drug: Bemiparin;   Drug: Placebo
27 Completed
Has Results
Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy
Conditions: Proliferative Diabetic Retinopathy;   Diabetic Macular Edema
Interventions: Drug: Ranibizumab;   Drug: Triamcinolone Acetonide;   Behavioral: Sham injection;   Procedure: Focal/grid laser
28 Terminated The ASCEND Study: A Study to Investigate the Safety and Clinical Effect of Nexagon to Treat Slow Healing Diabetic Foot Ulcers
Condition: Diabetic Foot Ulcer
Interventions: Drug: Nexagon®;   Drug: Nexagon® vehicle
29 Unknown  Efficacy of Surgical Treatment of Osteomyelitis in Diabetic Foot Ulcers
Conditions: Osteomyelitis;   Diabetic Foot;   Diabetic Foot Ulcers
Interventions: Procedure: Conservative surgery;   Drug: Ciprofloxacin;   Drug: Amoxicillin-Potassium Clavulanate Combination;   Drug: Sulfamethoxazole trimethoprim
30 Completed Treatment of Diabetic Macular Edema: Triamcinolone Injections Vs. Laser Photocoagulation
Conditions: Diabetic Retinopathy;   Diabetic Macular Edema;   DME
Intervention: Drug: Triamcinolone Acetonide
31 Unknown  Non-Invasive Assessment of Wound Healing With Optical Methods
Condition: Diabetic Foot Ulcers
32 Completed Evaluation of Blood-retinal Barrier Functional Alterations by Optical Coherence Tomography
Condition: Diabetic Retinopathy
33 Recruiting Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Single and Repeated Doses of Topical GSK1278863
Condition: Wound Healing
Interventions: Drug: GSK1278863;   Drug: Placebo
34 Completed Unilateral Bevacizumab for Bilateral Diabetic Macular Edema
Conditions: Diabetic Macular Edema;   Diabetic Retinopathy
Intervention: Drug: bevacizumab
35 Completed Intravitreal Bevacizumab Pretreatment for Reducing Preretinal Hemorrhage in Diabetic Vitrectomy
Condition: Proliferative Diabetic Retinopathy
36 Unknown  Bevacizumab as Adjunctive Treatment to Laser Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Condition: Proliferative Diabetic Retinopathy
Interventions: Procedure: Panretinal photocoagulation;   Procedure: Procedure: Panretinal Photocoagulation (PRP) Drug: Intravitreous injection of Bevacizumab
37 Not yet recruiting CSTC1 for Diabetic Foot Ulcers Phase II Study
Conditions: Diabetic Foot Ulcer;   Diabetes Mellitus;   Wounds
Interventions: Drug: CSTC1;   Drug: CSTC1 Matched vehicle
38 Completed Research Study in Patients With Persistent Macular Edema
Conditions: Diabetes;   Macular Edema;   Diabetic Retinopathy;   Retinal Disease;   Uveitis, Posterior
Intervention: Drug: DEX PS DDS®
39 Terminated Treatment of Diabetic Retinopathy With Open-Label Anecortave Acetate Sterile Suspension (15 mg)
Condition: Diabetic Retinopathy
Intervention: Drug: Anecortave Acetate Sterile Suspension (15 mg)
40 Unknown  Safety and Tolerability of NOVA63035 "Corticosteroid" in Patients With Diabetic Macular Edema Secondary to Diabetic Retinopathy
Condition: Diabetic Macular Edema
Intervention: Drug: NOVA63035 "Corticosteroid"

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years